Tiny balloon inside womb could help babies breathe
NCT ID NCT04052828
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a procedure called FETO, where a tiny balloon is placed in the windpipe of an unborn baby with severe congenital diaphragmatic hernia (CDH). The goal was to see if the balloon could be safely placed and removed to help the lungs grow. Four pregnant women participated, and the balloon was inserted between 27 and 29 weeks of pregnancy and removed around 34 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Goldballoon Detachable Balloon (GOLDBAL2) with Delivery Microcatheter
- What this could lead to
- If successful, this procedure could improve lung growth in fetuses with severe CDH, potentially increasing survival after birth.
- What could go wrong
- This is a very small pilot trial with only 4 participants, so results may not apply widely. The procedure carries risks like preterm labor or balloon complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
4 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed and dated consent * Stated willingness to comply with all study procedures and availability for the duration of the study * Singleton pregnancy * No pathogenic variants on microarray or pathologic findings on karyotype * Fetal echocardiogram with changes expected with CDH and no major structural cardiac defects * Fetal CDH (left or right) with severe pulmonary hypoplasia, defined as observed-to-expected (o/e) lung to head ratios (LHR) \<25% with liver up * Gestational age at FETO procedure: if o/e LHR \<25% will be done at 27 weeks plus 0 days to 29 weeks plus 6 days * Meets psychosocial criteria * Willing to reside within 30 minutes of Von Voigtlander Women's Hospital and ability to maintain follow up appointments * Patient has a support person (e.g. spouse, partner, friend, parent) that is available to stay with her for the duration of the pregnancy near Von Voigtlander Women's Hospital * Willing to comply with restrictions of daily living including inability to exercise, have intercourse, or return to work. Exclusion Criteria: * Multi-fetal pregnancy * History of latex allergy * History of preterm labor or incompetent cervix (requiring cerclage), short cervix (≤20mm), or uterine anomaly predisposing to preterm labor * Bilateral CDH, unilateral CDH with o/e LHR \> 25%, or unilateral CDH with o/e LHR \<25% but liver completely down in abdomen * Additional fetal or genetic abnormalities that would impact care after delivery or be known to have an impact on outcome * Maternal contraindications to elective fetoscopic surgery * Significant placental abnormalities (abruption, chorioangioma, accreta) known at time of enrollment and/or surgery * Maternal isoimmunization or neonatal alloimmune thrombocytopenia * Maternal HIV, Hepatitis B with positive surface antigen, Hepatitis C with presence of virus in maternal blood due to risk of fetal transmission during the procedure * No safe or feasible fetoscopic approach to balloon placement * Social work will meet with each patient to evaluate the social situation and support system. Identifiable issues of social instability or compliance with the protocol will exclude her as a potential candidate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital diaphragmatic hernia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 3D models bring a Baby's birth defect into focus before birth?
- Can a tiny balloon in the womb save babies born with a hole in their diaphragm?
- Teens' sports struggles after rare birth defect surgery: study seeks answers
- New trial could change how doctors help CDH babies at birth
- Pioneering fetal surgery aims to save babies born with a hole in their diaphragm
- Womb surgery for rare birth defect: will it save more babies?